🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of acetaminophen, asserting the companies concealed alleged dangers that the pain reliever presented to pediatric brain development.

This legal action follows a month after Donald Trump promoted an unproven link between taking Tylenol - referred to as acetaminophen - during pregnancy and autism spectrum disorder in children.

Paxton is filing suit against the pharmaceutical giant, which previously sold the drug, the exclusive pain medication suggested for expectant mothers, and the current manufacturer, which presently makes it.

In a statement, he claimed they "misled consumers by gaining financially from pain and promoting medication regardless of the risks."

The company states there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These corporations lied for decades, intentionally threatening countless individuals to increase profits," Paxton, from the Republican party, said.

The manufacturer said in a statement that it was "very worried by the dissemination of inaccurate information on the reliability of paracetamol and the potential impact that could have on the well-being of women and children in America."

On its online platform, the company also stated it had "consistently assessed the applicable studies and there is insufficient valid information that indicates a proven link between consuming acetaminophen and autism."

Organizations representing physicians and health professionals agree.

ACOG has declared paracetamol - the primary component in Tylenol - is one of the few options for pregnant women to treat pain and elevated temperature, which can create significant medical dangers if not addressed.

"In over twenty years of investigation on the utilization of acetaminophen in gestation, no reliable research has definitively established that the consumption of acetaminophen in any period of pregnancy causes neurodevelopmental disorders in offspring," the group said.

The lawsuit mentions current declarations from the Trump administration in asserting the drug is allegedly unsafe.

Recently, the former president generated worry from medical authorities when he advised expectant mothers to "resist strongly" not to take acetaminophen when ill.

Federal regulators then issued a notice that physicians should think about restricting the usage of acetaminophen, while also declaring that "a proven link" between the medication and autism in young ones has not been proven.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had vowed in April to undertake "comprehensive study program" that would determine the cause of autism spectrum disorder in a short period.

But experts warned that identifying a unique factor of autism - thought by researchers to be the result of a complicated interplay of inherited and surrounding conditions - would not be simple.

Autism is a type of lifelong neurodivergence and impairment that impacts how persons perceive and relate to the surroundings, and is diagnosed using medical professional evaluations.

In his legal document, Paxton - aligned with the former president who is campaigning for US Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the research" around acetaminophen and autism.

This legal action attempts to require the firms "remove any promotional materials" that states Tylenol is reliable for expectant mothers.

The court case parallels the complaints of a collection of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in 2022.

Judicial authorities threw out the legal action, saying studies from the parents' expert witnesses was not conclusive.